The Pilot and Feasibility (P and F) Program of the Baltimore Diabetes Research and Training Center (DRTC) is seeking applications to support new initiatives in diabetes-related biomedical, epidemiological or behavioral research.
The Baltimore DRTC is an NIH-funded joint-venture between the Johns Hopkins University and the University of Maryland. It is composed of Cores that are designed to support research in diabetes and related endocrine and metabolic diseases. The Baltimore DRTC is one of seven national centers.
Monetary awards funded by the P and F program provide limited support to the development of preliminary data sufficient for the funding of a research grant application, or to the testing of an innovative hypothesis which might have important implications or yield significant results for diabetes-related research.
ELIGIBILITY:
Faculty members at the University of Maryland or Johns Hopkins University who are (1) new investigators without current or past NIH support as principal investigators, OR (2) established grant supported investigators who have not previously worked in diabetes-related areas (3) OR established investigators in diabetes-related areas with a proposal for testing the feasibility of a new or innovative idea that is both diabetes-related and represents a clear and distinct departure from his/her ongoing research interests.
Applications for collaborative projects are strongly encouraged.
AWARDING MECHANISM:
After receiving the submissions, the P and F Steering Committee will review the applications for compliance with administrative guidelines. The proposals will then be sent to two reviewers, generally one reviewer from outside the institution and one internal reviewer at the collaborating institution, for peer review. We plan to award up to 3 applications this year depending on the number of fundable applications and the availability of funds.
SUBMISSION REQUIREMENTS:
- Pilot and Feasibility (P and F) Submission Form (available for download on this website)
- NIH PHS 398 Form Page 2: Summary, Relevance, Project/Performance Sites, Senior/Key Personnel, Other Significant Contributors, and Human Embryonic Stem Cells.
- NIH PHS 398 Form Page 4: Detailed Budget for Initial Budget Period (4/1/2012-3/31/2013) *
- NIH PHS 398 Form Page 5: Budget for Entire Proposed Project Period (Includes Budget Justification)*
- Biographical Sketch in NIH PHS 398 format.
- Research Plan on NIH PHS 398 Continuation Pages (see section PHS 398: Part I I-42 of PHS 398 Instructions for details; follow all instructions) Please limit your research plan to 3,000 words, not including references.
- A Brief Candidate Background Description, limited to 350 words, on NIH PHS 398 Continuation Page.
*The proposed budget for each award may be up to $50,000 year in direct costs (no indirect costs). One year of funding will be awarded. A second year of funding will be possible if productivity is demonstrated and if/when the DRTC is competitively renewed during the next cycle.
Pilot and Feasibility (P and F) Submission Form is attached.
All other forms are available at http://grants.nih.gov/grants/funding/phs398/phs398.html.
APPLICATION SUBMISSION:
Please submit your application via email by 5:00pm on Friday, February 17, 2012 as one PDF file to Michael Summa.
Awards will be presented during the 2012 Annual Diabetes Research Training Center Symposium, date TBA.
FACULTY CONTACT:
Sally Radovick, MD
Lawson Wilkins Professor of Pediatrics
The Johns Hopkins University School of Medicine
Director, Division of Pediatric Endocrinology
The Department of Pediatrics
600 North Wolfe Street, CMSC 406
Baltimore, MD 21287
Phone: 410-502-7556
Fax: 410-502-7580
sradovick@jhmi.edu
ADMINISTRATIVE CONTACT:
Michael Summa
Budget Specialist
The Johns Hopkins University School of Medicine
Department of Pediatrics
Divisions of Endocrinology and Metabolism
Phone: 410-502-5761
Fax: 410-502-7580
msumma1@jhmi.edu
More about the Baltimore DRTC